v3.25.4
Revenue
6 Months Ended
Nov. 30, 2025
Revenue from Contract with Customer [Abstract]  
Revenue

Note 6 – Revenue

 

Most of the Company’s revenue is generated by the performance of services to customers and recognized at a point in time based on the evaluation of when the customer obtains control of the products. Revenue is recognized when all performance obligations under the terms of a contract are satisfied, net of certain taxes and gain/loss resulting from changes in foreign currency. Revenue is recorded when customer acceptance is received and all performance obligations have been satisfied. Sales of goods typically do not include multiple products and/or service elements.

 

The table below summarizes the Company’s disaggregated revenue information:

                
  

Three Months Ended

November 30,

  

Six Months Ended

November 30,

 
   2025   2024   2025   2024 
Clinical trials  $40,903   $73,781   $65,042   $252,167 
Consulting fees   12,000    –    12,000    – 
Seminar fees   291    –    291    – 
Merchandise   72    467    133    968 
Total revenue  $53,266   $74,248   $77,466   $253,135 

 

Cost of revenue consists of third-party costs associated with patient stipends. At November 30, 2025, and November 30, 2024, cost of revenue was $18,643 and $16,165, respectively.